Background. Susceptibility to infection is in part genetically driven, and C57BL/6 mice resist various pathogens through the proinflammatory response of their M1 macrophages (MPs). However, they are susceptible to plague. It has been reported elsewhere that Mus spretus SEG mice resist plague and develop an immune response characterized by a strong recruitment of MPs.
The susceptibility of a patient to a given pathogen results from both environmental and genetic conditions. The innate immune response, first to develop after infection, directly depends on the host genetic background and is central to the interindividual heterogeneity observed during primary infection [1] . Faced with a fast-progressing and rapidly fatal infection, the robustness of the innate immune response is decisive in the outcome of the disease, because adaptive immunity mechanisms require days to develop and limit pathogen progression.
Macrophages (MPs) are among the key effectors of the innate immune response against pathogenic bacteria. Their functions include phagocytosis, killing of internalized organisms, release of antimicrobial factors, and recruitment of more effector cells by producing cytokines and chemokines. MPs are flexible cells with a highly dynamic phenotypic spectrum [2, 3] . The strongest antibacterial/proinflammatory profile is called M1, and at the opposite end, the "alternatively activated" MPs, designated M2, drive tissue healing and turn off inflammation by producing anti-inflammatory cytokines. M1 and M2 MPs promote T-helper 1 and T-helper 2 lymphocyte adaptive responses, respectively.
A well-studied example of genetically driven resistance to infection is the C57BL/6 (B6) mouse strain, which is resistant to peritonitis and to infection by Leishmania, Listeria, and Mycobacterium [4] [5] [6] . This capacity was associated with the M1 MP orientation [7] , as opposed to the susceptible BALB/c mouse strain, which displays an M2 response. However, the M1 genetic predisposition may not be sufficient to grant resistance to extremely potent pathogens. B6 mice, the prototypic M1 mice, are as susceptible to the plague agent Yersinia pestis [8, 9] as BALB/c mice [8] .
It has been reported elsewhere that Mus spretus SEG/Pas (SEG) inbred mice are highly resistant to bubonic plague [8] . Paradoxically, Y. pestis disseminates faster and causes earlier clinical signs of infection in SEG mice, but the animals survive [9] . Bacterial foci in the SEG spleen 2 days after infection were well contained with limited histological lesions, contrasting with the major necrotic lesions noted in the B6 spleen. This implies that an innate immune mechanism is protective in SEG mice. A strong recruitment of MPs was also observed in SEG but not B6 spleens, pointing toward MPs as potential mediators of SEG resistance. This was however intriguing because MPs are among the first cell populations targeted by Y. pestis in vivo [10] and can serve as an intracellular niche for Y. pestis multiplication [11] . Thus, the aim of the current study was to analyze the MP response of plague-resistant SEG mice to Y. pestis, in order to identify cellular mechanisms that drive the capacity of a mammalian host to resist plague.
MATERIALS AND METHODS

Bacterial Growth Conditions
The virulent Y. pestis strain CO92 and its pYV-cured derivative CO92∆pYV were cultured at 28°C on Luria-Bertani (LB) agar plates supplemented with 0.002% hemin (LBH) for 48 hours, followed by overnight culture in liquid LB broth at 37°C with shaking. Bacterial counts (measured in colony-forming units) were determined by plating serial dilutions on LBH. Experiments were performed in a biosafety level 3 laboratory.
Mice
The [8] . Female SEG or C57BL/6J (B6) mice (Charles River), aged 7-9 weeks, were infected subcutaneously with Y. pestis (100 colony-forming units) in abdominal skin and followed up for 14 days.
Cell Culture and In Vitro Stimulation
Peritoneal MPs collected from euthanized mice by lavage were plated in 48 wells plates for adherence, and adherent cells were further cultured in Roswell Park Memorial Institute 1640 medium supplemented with 5% fetal bovine serum. Bone marrow-derived MPs (BM-MPs) were obtained by culturing femoral bone marrow cells 6 days in medium containing 15% L929-conditioned medium. SEG and B6 MPs did not differ in size or shape, and MPs were homogenously F4/80+ CD11b + by flow cytometry. They were also CD80 low and Toll-like receptor (TLR) 4 + , indicating that they were not preactivated [12] . MPs were stimulated with 10 Y. pestis per MP and briefly centrifuged to favor bacterial contact (800G at 5 minutes). Lactate dehydrogenase and cytokines were tested after 5 hour, or 24 hours for nitric oxide (NO). To obtain splenic MPs, an erythrocyte-free suspension of splenocytes (3 × 10 6 /mL) in Roswell Park Memorial Institute 1640 medium was cultured for 2 hours to allow adherence, before washing with phosphate-buffered saline. To polarize MPs toward M1, BM-MPs were precultured with recombinant murine granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL; Immunotools) for 16 hours [13] .
Adoptive Transfer of MPs
B6 mice received autologous BM-MPs (10 6 cells in 100 μL) subcutaneously in the abdominal skin, followed 5 hours later by a second dose into the tail vein (2 × 10 6 cells in 200 μL), before subcutaneous infection with Y. pestis.
Statistical Analyses
The unpaired Student t test was used to compare groups. The Fisher exact test and the Mantel-Cox (log-rank) test were used to analyze survival (outcome and kinetics, respectively).
RESULTS
SEG and B6 MPs' Capacity to Kill Internalized Y. pestis
Peritoneal MPs from SEG and B6 mice exposed in vitro to Y. pestis CO92 (multiplicity of infection, 10) phagocytosed the bacterium with the same efficiency ( Figure 1A ). However, SEG MPs produced higher levels of NO ( Figure 1B) . Because NO is a potent antimicrobial agent, this suggested that SEG MPs killed internalized bacteria more efficiently. Indeed, the percentage of killed bacteria was significantly higher in SEG than in B6 MPs, and most bacteria internalized by SEG MPs were dead by 24 hours ( Figure 1C ). Therefore, SEG MPs exhibit a higher bactericidal activity against Y. pestis than B6 MPs. α, interleukin 6 [IL-6], and keratinocyte chemoattractant/ CXCL1), and less anti-inflammatory cytokines (granulocyte colony-stimulating factor and interleukin 10 [IL-10]) than B6 MPs ( Figure 2A ). The lower proinflammatory cytokines of B6 MPs was not caused by an IL-10 retroinhibition mechanism, because blocking IL-10 with antibodies had little or no effect on either cytokine profile (Supplementary Figure S1) . Compared with B6 MPs, the prototypic proinflammatory M1 [7] , the SEG profile was an enhanced M1. Different bacterial products preferentially trigger specific sets of cytokines [14] . To determine whether SEG MPs could preferentially respond to certain bacterial products, MPs were stimulated with well-defined TLR ligands: Escherichia coli lipopolysaccharide (TLR4 agonist), Pam3CSK (TLR1/2 agonist mimicking bacterial lipopeptides) and FSL-1, an agonist of TLR2/6 that favors IL-10 production on recognition of Y. pestis LcrV [14] . Whatever the TLR triggered, SEG MPs produced more proinflammatory cytokines (TNF-α and IL-6) and less IL-10 than B6 MPs ( Figure 2B ), indicating that the enhanced M1 profile was not ligand specific. The Y. pestis virulence plasmid pYV (pCD1) encodes Yersinia outer protein (Yop) cytotoxins that are injected into the host cell cytosol [15] and block intracellular signaling pathways critical for cytokine production [15] . We hypothesized that the enhanced M1 response could result from a lower capacity of Yops to block these signaling pathways in SEG MPs. When MPs were infected with a pYV-cured Y. pestis derivative (∆pYV), production of IL-6, TNF-α, and IL-10 was increased, as expected, compared with that of the wild-type strain ( Figure  2C ). However, even without the pYV, the levels of proinflammatory cytokines remained higher and the levels of anti-inflammatory cytokines lower in SEG than in B6 MPs ( Figure 2C ), indicating that Yops did not shape the response.
Activation of Intracellular Signaling Pathways in SEG and B6 MPs
The MP cytokine response triggered by bacteria results from the activation of various intracellular pathways. To determine whether these pathways could be activated differently in SEG MPs, BM-MPs from SEG and B6 mice were exposed to Y. pestis, and the activation levels of these different pathways were compared. The NF-κB pathway, central to cytokine production, was not differently activated ( Figure  3A) , as shown by comparable levels of IκBα phosphorylation, degradation, and resynthesis [16] . Production of TNF-α and other proinflammatory cytokines requires c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase pathways [17, 18] . JNK and p38 mitogen-activated protein kinase were not different in SEG MPs ( Figure 3A and 3D). The extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase pathway favors production of IL-10 [19] . ERK was more phosphorylated in B6 MPs ( Figure 3A and 3D) , potentially accounting for their higher IL-10 production. 
SEG MPs
and activator of transcription (STAT) 1 and STAT6 controlling M1 ("classic activation") and M2 ("alternative activation") signature genes, respectively. We observed ( Figure 3B , 3C, and 3D) that SEG MPs do not have an increased capacity to activate the STAT1 pathway in response to Y. pestis, but they show a markedly reduced ability to activate the STAT6 pathway in response to interleukin 4. Unphosphorylated factors were not different in the 2 species (not shown). That no factor phosphorylation was observed before infection confirmed that MPs were not preactivated.
SEG and B6 MPs Resistance to Y. pestis-Induced Apoptosis
Y. pestis can kill MPs by injecting Yop cytotoxins into their cytosol [15] , leading to death by apoptosis. The resistance of SEG mice to plague could result from a higher capacity of their MPs to resist this cytotoxic effect. SEG peritoneal MPs, but also spleen MPs and BM-MPs, were indeed able to better resist Y. pestis-induced killing than B6 MPs ( Figure 4A 
That Yop injection is required to kill MPs was confirmed here, because the pYV-cured Y. pestis failed to kill ( Figure 4B ). SEG MP survival could also result from a lower Yop injection into cell's cytosol. To test this, Yop injection was quantified using a Y. pestis producing a YopE-Cya reporter fusion protein [20] . The cyclic adenosine monophosphate level (produced by adenylate-cyclase Cya) was higher in SEG than in B6 MPs ( Figure  4C) , clearly excluding the possibility that a low Yop injection explained SEG MP survival.
Y. pestis can activate different death programs: a noninflammatory apoptosis [15] , but also an inflammatory death by pyroptosis [21] or a more extensive death by necrosis [22] . A different type of death program could explain the difference in cell death intensity observed in SEG and B6 MPs. Y. pestis-induced death of B6 and SEG MPs was inhibited by glycine, which acts as cytoprotectant by inhibiting nonspecific ions fluxes ( Figure 5A ), indicating that apoptosis in both MP types ends with necrosis features [23, 24] . Interleukin 1ß production accompanies death by pyroptosis in activated MPs [21] . Interleukin 1ß levels were low and comparable in SEG and B6 MPs ( Figure 5B ), excluding pyroptosis as a cause of lower SEG MP death. Caspases are the enzymes mediating apoptosis, and form 2 signaling cascades triggered by external (eg, Fas) or internal causes (eg, stress). Both pathways end by activation of effector caspase 3. Caspase 3 was activated in both MPs but was much higher in B6 than in SEG MPs infected with Y. pestis ( Figure 5C ). SEG MPs were as susceptible as B6 MPs to the apoptosis inducer staurosporin (Supplementary Figure S2) , indicating that SEG MP resistance to killing by Y. pestis was not due to an intrinsic defect of their apoptosis machinery. Therefore, the higher cytotoxic effect of Y. pestis on B6 MPs did not result from the triggering of different death programs in the 2 mouse strains but from a lower susceptibility of SEG MPs to Y. pestis-induced death.
Differen tial Activation of Apoptotic Pathways in SEG and B6 MPs
Like external death factors, Y. pestis is known to induce the "extrinsic" pathway of apoptosis, which signature is caspase 8 activation [25] . Caspase 8 was activated in B6 MPs exposed to Y. pestis, but, remarkably, caspase 8 activity was almost undetectable in SEG MPs ( Figure 6A ), indicating that a much lower activation of the extrinsic apoptosis pathway contributes to their resistance to Y. pestis-induced killing.
By activating the transcription of anti-apoptotic factors, the NF-κB pathway is a major switch for death processes [26] . We examined its contribution to SEG MP survival. The NF-κB inhibitor BMS-345541 considerably increased Y. pestis-induced death of B6 MPs, but not SEG MPs ( Figure 6B ).
The JNK factor is known to play a role in cell survival [27] . When JNK inhibitor SP600125 was added during MP infection, deaths of both B6 and SEG MPs were increased, reaching a level comparable in the 2 types of MPs ( Figure 6C ). Therefore, the JNK pathway is necessary to the resistance of MPs to Y. pestis but not sufficient. Together, these data suggest that the higher resistance of SEG MPs to Y. pestis-induced cytotoxicity results from the combination of a lower caspase 8 activation and the capacity to resist apoptosis independently of the NF-κB signaling pathway.
Reprogramming of B6 MPs to Display an Enhanced M1 Response to Y. pestis
It has been shown that GM-CSF increases the proinflammatory cytokine response of B6 MPs [13] . We first determined whether GM-CSF could induce the enhanced M1 response to Y. pestis. Indeed, IL-6 and NO levels of GM-CSF-treated B6 MPs increased significantly, to become higher than those of untreated SEG MPs ( Figure 7A and 7B). In contrast, IL-10 production was decreased in GM-CSF-treated B6 MPs to levels comparable to those of SEG and GM-CSF-treated SEG MPs ( Figure 7A ).
We then examined whether the enhanced M1 reprogramming could confer resistance to Y. pestis-induced apoptosis. Pretreated B6 MPs became even more resistant to Y. pestis cytotoxicity than SEG MPs and survived as well as GM-CSF-treated SEG MPs ( Figure 7C ). Therefore, resistance to apoptosis and the high M1 cytokine response are functionally linked. Together, our results demonstrate that B6 MPs do have the capacity to display a higher M1/anti-apoptotic response to Y. pestis, and therefore the difference between B6 and SEG MPs is due to different functional programs, controlled by an unknown genetic element.
Contribution of an enhanced M1/Anti-Apoptotic Response to Resistance to Bubonic Plague
We examined whether grafting MPs with the enhanced M1 profile to susceptible mice conferred resistance. SEG and B6 mice are not histocompatible, and grafting SEG MPs to F1 (B6 × SEG) B C A mice would not be informative because F1 mice are already 75% resistant to plague [8] . We therefore injected normal or GM-CSFtreated B6 BM-MPs into B6 mice, before a subcutaneous challenge with Y. pestis. Mice having received polarized B6 MPs had a longer time to death (mean [standard error of the mean], 6.9 [0.5] days; Figure 7D ) than nongrafted B6 mice (4.5 [0.2] days) or B6 mice that had received untreated B6 MPs (5.8 [0.3] days). Furthermore, none of the nongrafted mice survived. Grafting-enhanced M1-polarized MPs provided 25% survival (P < .05), whereas untreated B6 MPs had no significant effect (10% survival). GM-CSF-treated MPs also had a strong favorable effect on mouse survival kinetics (log-rank test: P < .001). Taken together, these data indicate that MPs displaying a high M1/antiapoptotic response contribute significantly to the capacity of a host to resist plague. . Bone marrow-derived macrophages (BM-MPs) from B6 mice reprogrammed for enhanced M1 enable survival of bubonic plague when grafted to autologous susceptible mice. SEG and B6 BM-MPs were incubated with 50 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF) (+) or not (-) for 16 hours before exposure (+) or not (-) to Yersinia pestis for 5 hours (multiplicity of infection, 10). A-C, Cytokines (A), nitric oxide (NO) (B), and cell death (C) were then measured. Data represent means with standard errors of the mean for MPs from 6 mice (1 representative experiment of 2). IL-6, interleukin 6; IL-10, interleukin 10; NS, not significant (P ≥ .05). *P < .05; †P < .01; ‡P < .001. D, B6 BM-MPs preincubated with or without GM-CSF were injected intravenously and subcutaneously into B6 mice just before subcutaneous infection of the animals with 100 colony-forming units of Y. pestis. Nongrafted mice were also infected as control (no cells). Survival was followed for 14 days, and survival curves represent 20 mice, pooled from 2 independent experiments. Abbreviation: NS, not significant. (P ≥ .05). *P < .05 (Fisher exact test).
DISCUSSION
MPs play a crucial role in the capacity of B6 mice to resist diverse bacterial diseases, a capacity associated with the programming of their MPs to display an M1 response [7] . However, this skewing is not sufficient to protect B6 mice against plague. We had previously reported that SEG mice resist bubonic plague, with a response characterized by an active recruitment of monocytes/ MPs in infected organs [9] . The current study further determined and characterized the role MPs play in SEG capacity to survive plague, by comparing SEG and B6 MPs exposed in vitro to Y. pestis. We report that 3 components of the MP response that may actively participate in the control and killing of this bacterium were more effective in SEG than in B6 MPs.
The first was the higher production of NO by SEG MPs on infection with Y. pestis. The plague bacillus has to subvert NO production to survive and multiply intracellularly [11] , so the capacity of SEG MPs to produce higher amounts of this toxic compound may explain their higher bactericidal activity against Y. pestis. Second, SEG MPs resisted Y. pestis-induced apoptosis. The plague bacillus, like other pathogenic bacteria, induces programmed cell death by injecting toxins into host cells [28] . By resisting this apoptosis, more SEG MPs could thus exert their bactericidal activity. Finally, the cytokine response of SEG MPs was even more strongly proinflammatory. In laboratory mice, inflammation is lacking in early plague [29] , creating a local permissive environment enabling Y. pestis growth [30] . In SEG mice, this preinflammatory phase is much shorter [9] , and this could be explained by the stronger proinflammatory action of their MPs. All together, the combination of a strong bactericidal activity, abundant production of proinflammatory cytokines, and the capacity to better resist Y. pestis-induced apoptosis strongly argued for a MP role in the resistance of SEG mice to bubonic plague. Transferring MPs exhibiting a SEGlike response significantly enhanced the survival of susceptible B6 mice to plague, confirming that MPs play a key role in host genetic resistance to plague.
The M1 response was initially characterized by a cytokine-mediated proinflammatory response and a potent bactericidal activity [7] . Our analysis shows that the resistance of SEG MPs is not limited to their proinflammatory and bactericidal response but also involves the resistance to bacteria-induced apoptosis. These properties have been observed independently but have not been associated until now. Linking the 2 properties is JNK, a known regulator of cell death [27, 31] , which also induces the production of inflammatory cytokines [32] and is required for SEG MPs to survive apoptosis. Similarly, caspase 8, which is involved in apoptosis via the extrinsic pathway [25, 33] also inhibits M1 polarization of MPs [34] and is not activated in SEG MPs. Therefore, this suggests that the proinflammatory response and resistance to apoptosis are coordinated as part of a unique functional program conferring an effective response to pathogens.
It has been reported elsewhere that SEG resistance to plague is genetically controlled by at least 4 distinct genetic loci in the genome [8, 35] . However, these loci encompass more than a thousand genes, including multiple genes coding for actors of inflammation, and further reduction of the loci will be needed. Interestingly, B6 MPs can display the enhanced M1 response after receiving an external polarization signal demonstrates that the necessary genetic determinants are functional. This indicates that the response of B6 and SEG MPs is under the control of upstream signals (enhancers, regulators, transcription factors) that differentially activate or inhibit the same signaling pathways. In agreement, SEG MPs have a decreased responsiveness via STAT6, a transcription factor central to M2/alternative activation that counteracts the M1 response. Therefore, SEG MPs may have an enhanced M1 profile due to resistance to M2 polarization.
We evaluated the possibility of injecting GM-CSF directly into mice at the time of infection, following conditions that protected rats against Staphylococcus aureus [36] ; however, GM-CSF did not improve mouse survival of plague (data not shown). Although GM-CSF is one of the most studied immunostimulants in humans sepsis ( [37, 38] ), there has been a consistent lack of survival benefit in these studies, with failure to confirm promising in vitro results. GM-CSF is not produced spontaneously by SEG MPs and is not produced by SEG MPs not more than by B6 MPs on infection (not detailed), and another factor probably exerts the observed effects.
There is hope that the present findings may be translated to human disease if safe treatments increasing the M1/apoptosis resistance profile are found. The SEG mice suggest that having more active MPs is not pathogenic. In spite of the enhanced response of their MPs, they are not hypersensitive to lipopolysaccharide [39] and no autoimmune disease, chronic inflammation disease, or severe inflammatory tissue damage was observed during infection by various pathogens ( [40] and our unpublished observations). In humans, increasing inflammation must be used with care to avoid potential adverse effects [41] . Transient enhancement of MP functions would be preferable, and an adequate treatment dosage must be found. However, functional polarization is not permanent activation, and an activating signal is required to cytokines and NO release. Enhanced proinflammatory MPs could be induced by means of cytokines, possibly from the GM-CSF family, but also immunostimulants such as CpG oligodeoxynucleotides [42] . There is increasing recognition that nonspecific MP memory exists, also in humans, called "trained immunity", which results from long-lasting epigenetic modifications by factors such as β-glucan or bacille Calmette-Guérin (BCG). Those could be used to enhance innate immunity [43] . Such a mechanism provides hope that treatments fostering innate immunity could be beneficial against plague and other infectious diseases and might be proposed in plague-endemic regions as a prophylactic measure to limit the risk of contagion. In conclusion, our study unraveled the important role played by MPs in the innate resistance of mice to bubonic plague. We show that a classic M1 response is not sufficient to survive plague and that a more proinflammatory MP response is required. Such a response is driven by a preprogrammed capacity to activate signaling pathways that elicit a potent proinflammatory response and resistance to Y. pestis-induced apoptosis. This response could also take place and confer resistance to other highly lethal diseases, such as viral hemorrhagic fevers, which skew MP functions to their benefit [44] [45] [46] . Skewing MPs toward an enhanced M1 phenotype could represent a strategy to combat otherwise fatal infectious diseases.
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